MedPath

SAPROPTERIN DIHYDROCHLORIDE

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . SAPROPTERIN DIHYDROCHLORIDE powder for oral solution Initial U.S. Approval: 2007

Approved
Approval ID

2e13a3b5-e4df-4d5c-9b26-02a7006a7c3e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 29, 2020

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SAPROPTERIN DIHYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-873
Application NumberANDA210027
Product Classification
M
Marketing Category
C73584
G
Generic Name
SAPROPTERIN DIHYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 18, 2020
FDA Product Classification

INGREDIENTS (5)

SAPROPTERIN DIHYDROCHLORIDEActive
Quantity: 500 mg in 1 1
Code: RG277LF5B3
Classification: ACTIB
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
POTASSIUM CITRATEInactive
Code: EE90ONI6FF
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SAPROPTERIN DIHYDROCHLORIDE - FDA Drug Approval Details